adminの記事一覧

A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.

Am J Physiol Renal Physiol. 305(12): F1796-1803, 2013.PubMed

The role of urinary liver-type fatty acid-binding protein in critically ill patients.

J Korean Med Sci. 28(1): 100-105, 2013.PubMed

Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.

Diabetes Care. 36(5): 1248-1253, 2013.PubMed

Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.

J Cardiol. 60(3): 168-173, 2012.PubMed

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.

Diabet Med. 29(8): e184-190, 2012.PubMed

Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.

Eur J Clin Invest. 42(5): 557-563, 2012.PubMed

Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.

Hypertens Res. 35(11): 1058-1062, 2012.PubMed

Usefulness of Urinary Biomarkers in Early Detection of Acute Kidney Injury After Cardiac Surgery in Adults.

Circulation Journal. 76(1): 213-220, 2012.PubMed

Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery.

Ann Thorac Surg. 93(2): 577-583, 2012.PubMed

Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury.

Hypertension. 60(4): 973-980, 2012.PubMed